Aurobindo Pharma’s arm step-down gets Establishment Inspection Report for Telangana injectable facility

27 Jun 2024 Evaluate

Aurobindo Pharma’s step-down subsidiary -- Eugia SEZ has received Establishment Inspection Report for Telangana facility, classifying the facility as Voluntary Action Indicated (VAI). The U.S. Food and Drug Administration (USFDA) had conducted an inspection at the injectable facility of Eugia SEZ, situated at Polepally Village, Jadcherla Mandal, Mahaboobnagar District, Telangana, from February 19, 2024 to February 29, 2024. 

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1223.65 3.45 (0.28%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.